[The effects of cancer treatments at the end of life: a clinical, ethical, and organizational issue].

The use of cancer treatments in the terminal stages of life is an increasingly important clinical, ethical, and organizational issue. Despite recommendations from major scientific organizations to reduce active treatments for patients with a limited life expectancy, significant evidence shows that these therapies continue to be used even during the final days or weeks of life. This trend raises important questions regarding the quality of care, the appropriate balance between risks and benefits, the effective use of healthcare resources, communication between physicians and patients, and the incorporation of palliative care into the overall oncological treatment plan. Given these considerations, it is essential to analyze the clinical and organizational factors that influence these decisions. The goal is to develop effective strategies that promote more appropriate care, encourage the earlier integration of palliative care, and reduce the use of unnecessary or potentially harmful treatments during the terminal phases of illness.